Non-Invasive Test for Estimation of Liver Fibrosis
In 2015 the digestive disorders were the second leading cause of morbidity among Mongolian population. The observed mortality from cancer in 2013 was 23.4% including liver cancer which is the first most common cause of cancer death. Furthermore, the digestive disease related death accounts for 4.7% of all mortality. Recently many noninvasive markers for assessing liver fibrosis have been developed, and they are frequently used in clinical practice. FIB4 index had a predictive value to confirm the existence of significant fibrosis with a specificity of 74% and a sensitivity of 70% and APRI score had a sensitivity of 89% and a specificity of 75%.